N-Cyclopentyl-4-[5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine | 474303-72-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-Cyclopentyl-4-[5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine
• 英文别名: N-cyclopentyl-4-[5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine
• CAS: 474303-72-5
• 化学式: C₂₃H₂₁Cl₂N₅O
• 分子量: 454.359
• InChiKey: UPURSWNGJDCEHG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  31
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  64.3
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-Cyclopentyl-4-[5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine 以 环戊胺 为溶剂， 以to give 70 mg (80%) of N-{4-[5-chloro-7-(cyclopentylamino)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinyl}-N-cyclopentylamine as a solid的产率得到N-{4-[5-chloro-7-(cyclopentylamino)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinyl}-N-cyclopentylamine
  参考文献：
  名称：

  Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds

  摘要：

  本发明提供了式(I)的化合物:其中所有变量如本文所定义，包含它们的药物组合物，制备它们的方法以及它们作为药物剂的用途。

  公开号：

  US20050192303A1
• 作为产物：
  描述：

  4-[5-chloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopentyl-2-pyrimidinamine 在 正丁基锂 、 四氯化碳 作用下， 生成 N-Cyclopentyl-4-[5,7-dichloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-2-pyrimidinamine
  参考文献：
  名称：

  Pyrazolopyridines with potent activity against herpesviruses: Effects of C5 substituents on antiviral activity

  摘要：

  Synthesis of a series of 5-substituted as well as 5,7-disubstituted 3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-phenylpyrazolo [1,5-a]pyridin-7-amines with potent activity against herpes simplex viruses is described. Synthetic approaches allowing for variation of the substitution pattern are outlined and resulting changes in antiviral activity are highlighted. Several compounds with in vitro antiviral activity similar to or better than acyclovir are described. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.11.120

文献信息

• Therapeutic compounds
  申请人：——

  公开号：US20040142941A1

  公开（公告）日：2004-07-22

  The present invention provides compounds of formula (I), pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents. 1

  本发明提供了式（I）化合物，包含其的制药组合物，制备该化合物的过程以及其用作制药剂的用途。
• PYRAZOLO[1,5-A]PYRIDINE DERIVATIVES
  申请人：SmithKline Beecham Corporation

  公开号：EP1385847B1

  公开（公告）日：2005-06-01
• US6962914B2
  申请人：——

  公开号：US6962914B2

  公开（公告）日：2005-11-08
• US7030134B2
  申请人：——

  公开号：US7030134B2

  公开（公告）日：2006-04-18
• Pyrazolopyridines with potent activity against herpesviruses: Effects of C5 substituents on antiviral activity
  作者：Kristjan S. Gudmundsson、Brian A. Johns、Scott H. Allen

  DOI：10.1016/j.bmcl.2007.11.120

  日期：2008.2

  Synthesis of a series of 5-substituted as well as 5,7-disubstituted 3-[2-(cyclopentylamino)-4-pyrimidinyl]-2-phenylpyrazolo [1,5-a]pyridin-7-amines with potent activity against herpes simplex viruses is described. Synthetic approaches allowing for variation of the substitution pattern are outlined and resulting changes in antiviral activity are highlighted. Several compounds with in vitro antiviral activity similar to or better than acyclovir are described. (C) 2007 Elsevier Ltd. All rights reserved.